CloudTalk

Author: Agentic NewsRoom

  • Quadric: On-Device AI Chips Revolutionize Computing

    Quadric: On-Device AI Chips Revolutionize Computing

    The hum of servers, usually a constant drone, seemed to quiet slightly, or maybe that’s how the supply shock reads from here. Inside Quadric’s engineering lab, the team was running thermal tests on the new M300 chip, slated for release in early 2027, according to their roadmap. The goal: to enable AI processing directly on devices, bypassing the need for constant cloud connectivity.

    It’s a strategic pivot, as the industry begins to recognize the limitations of cloud-dependent AI. Quadric, founded with the aim of helping companies and governments, sees the potential in programmable on-device AI chips. They’re designed to run fast-changing models locally. This means quicker response times and enhanced data privacy, key selling points in an increasingly security-conscious world.

    “We’re seeing a significant shift,” said analyst Maria Chen from Forrester, during a recent industry briefing. “The demand for on-device inference is surging, and companies like Quadric are well-positioned to capitalize. We project the market to reach $15 billion by 2028.” That’s a bold number, considering the sector was still nascent just a few years ago. But the need is there: think of self-driving cars needing instant reactions, or edge devices in remote locations with limited bandwidth.

    The technical challenges are significant. Building these chips requires advanced manufacturing, and the global supply chain, still recovering from recent disruptions, adds another layer of complexity. Export controls also play a major role. Quadric, like many in the industry, has to navigate the complex web of US and international regulations. The company is likely looking at options for domestic procurement policies in China, which could influence their strategy.

    Earlier today, the team was reviewing the performance metrics for the M100, which is already in use. The focus now is on the M300, which promises a substantial performance leap. The engineers were huddled around monitors, analyzing the data. The atmosphere was focused, the air thick with anticipation. The M300 is expected to offer a 4x performance increase over the M100, according to internal projections.

    The shift to on-device AI is more than a technological evolution; it’s a strategic move. It gives companies and governments greater control over their data and operations. Quadric is, in a way, at the forefront of this transformation. Their success will depend on their ability to deliver on their promises, navigate the complex regulatory landscape, and, of course, stay ahead of the competition.

  • Tiger Global & Microsoft Exit PhonePe Ahead of IPO

    Tiger Global & Microsoft Exit PhonePe Ahead of IPO

    The numbers were coming in fast, screens flickering in the subdued light of the Bloomberg terminal room. It was January 22, 2026, and the news was breaking: Tiger Global and Microsoft were set to fully exit their positions in PhonePe, the digital payments firm backed by Walmart. The move, announced ahead of PhonePe’s initial public offering, sent a ripple through the market, or so it seemed.

    Walmart, however, wasn’t following suit. Instead, the retail giant planned to retain its majority stake, while also offloading up to 45.9 million shares. The shift in strategy was immediately apparent, and the air in the room felt thick with speculation. What did it mean? Did the exits signal a lack of faith, or a strategic realignment? Or something else entirely?

    The atmosphere was tense, the chatter on the conference call, muted. Analysts were already running the numbers, trying to make sense of the valuation implications. One expert, speaking from the Peterson Institute for International Economics, suggested the move could reflect a broader trend. “It’s about portfolio diversification, and maybe, just maybe, a reassessment of risk in the current climate,” she said, her voice a steady counterpoint to the rising tide of market noise.

    Tiger Global and Microsoft’s decision to fully exit, while Walmart held steady. It was a stark contrast.

    The financial mechanics were intricate, the details of the IPO still unfolding. But the core story was clear: major players were making significant moves. The market’s reaction, of course, was the key.

    The implications were vast, and the possible scenarios, numerous. A successful IPO would validate PhonePe’s growth trajectory, but it also opened the door to new risks. Tax implications, regulatory hurdles, and evolving consumer behavior—all were factors that would shape the company’s future.

    The analysts continued to tap at their spreadsheets, the data points flashing across their screens, the sound a low hum. It was a complex, evolving situation, and the final chapter, still unwritten.

    And it was clear, the story wasn’t over.

  • Tiger Global & Microsoft Exit PhonePe IPO: Market Shift

    Tiger Global & Microsoft Exit PhonePe IPO: Market Shift

    The news hit the wires on January 22, 2026, a Tuesday, and the trading floor felt… subdued. Or maybe it was just the usual mid-week quiet, the air conditioning humming a steady drone, analysts already tapping away at spreadsheets. Tiger Global and Microsoft were finally pulling out of PhonePe, the Walmart-backed digital payments firm, via its upcoming IPO. Not a complete surprise, but the scale of the exit was notable.

    Reports indicate that Tiger Global and Microsoft are offering their full stakes. Walmart, on the other hand, is retaining its controlling interest, though it’s also selling a chunk – up to 45.9 million shares. It’s a shift, a repositioning, the kind that always makes you wonder what the smart money sees that the rest of us don’t.

    Details are still emerging, but the implications are already echoing. The market’s initial reaction? Muted, as far as could be seen. A quick glance at the early trading indicators told the story. This isn’t necessarily a sign of trouble, of course — it could be a strategic move to capitalize on the IPO’s potential. Still, some analysts are cautioning against reading too much into the initial reaction, suggesting a wait-and-see approach. As one financial analyst from a well-known research firm, said, “These kinds of exits are complex, reflecting a blend of portfolio strategy, market timing, and potentially, tax considerations.”

    This isn’t the first time we’ve seen this kind of play. There’s a pattern, a rhythm, to these large-scale exits. The timing, the valuation, the overall market conditions – all play a part, a complicated dance. It’s a game of chess, in a way. The players are shifting their pieces, and the board is constantly changing.

    The exit of these major investors raises several questions. What does this mean for PhonePe’s future? For Walmart’s long-term strategy in the Indian market? And, perhaps most importantly, what does it signal about the broader tech investment landscape? The answers, as always, are not straightforward.

    The details will become clearer in the coming weeks. But the initial move is made. The stakes are set.

  • AI Citation Crisis: Hallucinations at NeurIPS Conference

    AI Citation Crisis: Hallucinations at NeurIPS Conference

    AI’s Citation Crisis: Hallucinations Plague Prestigious NeurIPS Conference

    The field of artificial intelligence is experiencing a rapid evolution, with advancements occurring at an unprecedented pace. However, as AI models become more sophisticated, so do the challenges associated with their use. One such challenge, highlighted by research from the startup GPTZero, is the proliferation of “hallucinated” citations in academic papers.

    The Problem: AI-Generated Citations

    The core issue revolves around AI models generating citations that do not exist or misrepresent the content of the cited works. This phenomenon, often referred to as “AI slop,” poses a significant threat to academic integrity. It undermines the foundations of research, making it difficult to verify the accuracy and originality of published work. The implications of this are far-reaching, potentially leading to the spread of misinformation and the erosion of trust in the scientific community.

    According to the recent report, this issue has surfaced within NeurIPS, one of the most respected AI conferences. The very fact that this is happening at such a high-profile event underscores the severity of the problem. It suggests that even the most rigorous peer-review processes are struggling to keep pace with the capabilities of increasingly advanced AI models.

    The Investigation: GPTZero’s Findings

    GPTZero, the startup behind the investigation, used its expertise to detect these fabricated citations. Their research highlights the challenges that prestigious conferences face in the age of AI. The findings are a stark reminder of the need for robust methods to detect and prevent the misuse of AI in academic settings.

    The research from GPTZero focuses on the “what” of the issue: specifically, the presence of “hallucinated citations” in academic papers. This “what” is further contextualized by the “where” – the NeurIPS conference. The “how” of the research involves the application of GPTZero’s detection capabilities. The “why” of the investigation is to highlight the challenges that prestigious conferences face in the age of AI. This includes the erosion of academic integrity and the potential spread of misinformation.

    Impact and Implications

    The presence of fabricated citations has several detrimental effects. It casts doubt on the validity of research findings, making it difficult for other researchers to build upon the work. It also wastes the time of reviewers and readers who may attempt to locate these non-existent sources. Furthermore, it erodes the public’s trust in the academic process. The integrity of research is paramount, and the proliferation of “AI slop” threatens to undermine this.

    The fact that this is happening at NeurIPS, a premier venue for AI research, is particularly concerning. NeurIPS represents the cutting edge of AI, and the presence of these issues suggests that the problem is widespread and not limited to less prestigious venues. This also calls into question the effectiveness of current peer-review processes.

    Addressing the Crisis

    Addressing the issue of AI-generated citations requires a multi-faceted approach. First, conferences and journals need to improve their screening processes to detect fabricated citations. This could involve using AI-powered tools to check for non-existent references and verifying the accuracy of citations. Second, researchers should be educated on the ethical implications of using AI and the importance of academic integrity. Finally, the AI community must develop and promote best practices for responsible AI use in research.

    The “when” of this crisis is now. The issue demands immediate attention. The findings from GPTZero serve as a critical wake-up call for the AI research community.

    Conclusion

    The discovery of “hallucinated” citations in papers submitted to NeurIPS is a serious issue. It underscores the challenges that the AI community faces as AI technologies become more sophisticated. Maintaining academic integrity is crucial, and the community must take steps to address this problem. This involves improving detection methods, educating researchers, and promoting responsible AI practices. Only through a concerted effort can the AI community safeguard the integrity of its research and maintain public trust.

  • AI Citation Crisis: Hallucinations at NeurIPS Conference

    AI Citation Crisis: Hallucinations at NeurIPS Conference

    AI’s Citation Crisis: Hallucinations Plague Prestigious NeurIPS Conference

    The rise of artificial intelligence has brought with it a wave of innovation and, unfortunately, a troubling new phenomenon: AI-generated “hallucinations.” These aren’t the visual or auditory experiences one might associate with the term, but rather the creation of plausible-sounding, yet completely fabricated, information by AI systems. A recent investigation highlights a particularly concerning manifestation of this issue within the realm of academic research.

    The focus of this investigation, conducted by the startup GPTZero, centers on the prestigious NeurIPS (Neural Information Processing Systems) conference. GPTZero‘s research reveals the presence of “hallucinated” citations within papers accepted and presented at NeurIPS. These citations, while appearing legitimate at first glance, point to sources that either don’t exist or don’t contain the information referenced. The implications are significant, raising serious questions about the integrity of the research process and the challenges faced by academic institutions in the age of sophisticated AI.

    The Problem of AI

  • OpenEvidence Valuation Soars to $12B: Thrive & DST Lead

    OpenEvidence Valuation Soars to $12B: Thrive & DST Lead

    OpenEvidence Soars to $12B Valuation: Thrive and DST Lead New Funding Round

    In a significant development for the tech and medical information sectors, OpenEvidence, a leading medical info database, has reached a valuation of $12 billion. This impressive figure, announced on January 21, 2026, marks a doubling of its valuation since its previous funding round in October. The new investment round is spearheaded by Thrive and DST, indicating a strong vote of confidence in OpenEvidence’s continued growth and potential.

    The rapid ascent of OpenEvidence in valuation underscores the increasing importance of reliable and accessible medical information in today’s world. Its database serves as a critical resource for healthcare professionals, researchers, and other stakeholders. This growth comes despite increasing competition from model makers and other players in the tech landscape. The fact that OpenEvidence has not only sustained but accelerated its valuation growth speaks volumes about its market position and the value it provides.

    Key Players and Their Roles

    The recent funding round highlights the strategic importance of OpenEvidence and the confidence of its investors. Thrive and DST, the primary investors in this round, are well-known for their strategic investments in high-growth companies. Their involvement provides both capital and valuable industry expertise. The fact that these established investment firms are willing to back OpenEvidence at this valuation indicates the perceived long-term potential of the company and its business model.

    Market Context and Future Prospects

    The medical information landscape is constantly evolving, with new technologies and data sources emerging regularly. OpenEvidence has positioned itself as a key player in this space by curating and providing access to a comprehensive and reliable database. The company’s ability to maintain its growth trajectory, even in the face of competition, demonstrates its strong market position and the value it delivers to its users.

    The new funding will likely be used to further develop and expand OpenEvidence’s database, as well as to invest in new technologies and services. With the backing of Thrive and DST, the company is well-positioned for continued success. This investment round will enable OpenEvidence to maintain its competitive edge and continue to innovate in the medical information space. The company’s success is a testament to the increasing reliance on data-driven insights in healthcare, and its future looks bright.

    The rapid growth and high valuation of OpenEvidence reflect broader trends in the tech and healthcare industries, where data-driven solutions are becoming increasingly important. The company’s success underscores the value of reliable and accessible medical information and its potential for continued growth in the years to come.

    Source: TechCrunch

  • OpenEvidence Valuation Soars to $12B with Thrive, DST Funding

    OpenEvidence Valuation Soars to $12B with Thrive, DST Funding

    OpenEvidence Hits $12B Valuation, Bolstered by New Funding

    In a remarkable display of investor confidence, OpenEvidence, the medical information database, has achieved a $12 billion valuation. This significant milestone, announced on January 21, 2026, marks a substantial increase from its previous valuation just a few months prior. The new funding round was led by prominent investment firms Thrive and DST, underscoring the company’s continued growth trajectory and the perceived value of its services.

    A Rapid Ascent in Valuation

    The impressive valuation of OpenEvidence is particularly noteworthy given the competitive landscape. The company has essentially doubled its valuation since its last funding round in October. This rapid growth highlights the increasing demand for reliable, comprehensive medical information, as well as the investors’ belief in OpenEvidence’s ability to navigate the challenges posed by competitors. The investment led by Thrive and DST is a clear indicator of the market’s positive outlook.

    The Players: Thrive, DST, and OpenEvidence

    The key players in this financial success story are OpenEvidence itself, along with the investment firms Thrive and DST. OpenEvidence, the core of this narrative, provides a critical service in the medical field by curating and maintaining a robust database of medical information. The new funding round, spearheaded by Thrive and DST, will likely fuel further expansion and development of their platform. Their contributions are pivotal for OpenEvidence’s continued success.

    The Significance of the Investment

    This new round of funding is not just a financial injection; it is a vote of confidence in OpenEvidence’s business model and its potential for future growth. The fact that the valuation has doubled in a short period suggests that investors see significant opportunities for OpenEvidence to further consolidate its position in the market. The investment from Thrive and DST is a strategic move, positioning them at the forefront of the medical information landscape.

    Navigating the Competitive Landscape

    The medical information sector is increasingly competitive, with several players vying for market share. Despite this, OpenEvidence has managed to not only maintain its position but also to significantly increase its valuation. This suggests that OpenEvidence has a unique value proposition, potentially through its data quality, its user-friendly interface, or its strategic partnerships. The ability to thrive amidst competition is a testament to the strength of its underlying business model.

    Looking Ahead

    The future looks bright for OpenEvidence. With the backing of Thrive, DST, and other investors, the company is well-positioned to continue its expansion and innovation. The increased valuation reflects the market’s recognition of OpenEvidence’s importance in the medical field and its potential for long-term success. As the landscape continues to evolve, OpenEvidence is poised to remain a key player, providing crucial medical information to professionals worldwide.

    Source: TechCrunch

  • PraxisPro Secures $6M Seed Funding for AI Medical Sales Training

    PraxisPro Secures $6M Seed Funding for AI Medical Sales Training

    PraxisPro Secures $6M Seed Funding to Revolutionize Medical Sales Training with AI

    In a significant boost for the medical sales sector, PraxisPro, a startup leveraging artificial intelligence to transform sales training, has successfully closed a $6 million seed funding round. The investment, led by AlleyCorp, underscores the growing interest in AI-driven solutions for specialized professional development. Founded by a former pharma sales rep, PraxisPro is poised to disrupt the traditional methods of training medical product sales representatives.

    The Innovative Approach of PraxisPro

    PraxisPro distinguishes itself by utilizing small language model AI to provide highly targeted and effective coaching. This approach focuses specifically on the nuanced requirements of medical product sales. The training programs are designed to enhance the product knowledge, sales techniques, and overall performance of sales representatives. This specialized focus aims to address the unique challenges and complexities inherent in the medical sales landscape.

    The company’s innovative use of AI allows for personalized training experiences, adapting to the individual needs and learning styles of each sales rep. This tailored approach is a departure from the one-size-fits-all training methods often seen in the industry. The investment from AlleyCorp will enable PraxisPro to further refine its AI-driven coaching platform and expand its reach within the medical sales market.

    Key Players and the Investment

    The seed funding round, which closed on January 21, 2026, marks a pivotal moment for PraxisPro. The investment from AlleyCorp provides both financial backing and strategic guidance. AlleyCorp, known for its investments in early-stage tech companies, recognizes the potential of PraxisPro’s AI-powered coaching model to reshape the medical sales training landscape. The founder, a former pharma sales rep, brings invaluable industry experience and a deep understanding of the challenges faced by sales professionals in this field.

    The investment will be used to enhance the company’s AI training platform, expand its team, and broaden its market reach. The focus on small language models allows for cost-effective and efficient training solutions. This approach enables PraxisPro to offer accessible and impactful training programs to a wider audience of medical sales representatives.

    Why This Matters for the Future

    The success of PraxisPro highlights a broader trend: the integration of AI into professional development. This technology offers the potential to create more effective, personalized, and accessible training programs. For medical sales, this means better-prepared sales representatives, improved product knowledge, and ultimately, more effective communication with healthcare professionals. This, in turn, can lead to better patient outcomes and more efficient healthcare practices.

    The funding also reflects the growing recognition of the importance of specialized training in the medical sales industry. As medical products and technologies become increasingly complex, the need for highly skilled sales professionals grows. PraxisPro’s AI-driven approach is well-positioned to meet this demand, providing a cutting-edge solution for training and development.

    Conclusion

    PraxisPro’s $6 million seed funding round is a significant milestone for the company and the medical sales industry. With the backing of AlleyCorp and the innovative use of AI, PraxisPro is set to make a lasting impact on how medical sales representatives are trained and developed. This investment not only supports the growth of a promising startup but also contributes to the advancement of effective, technology-driven solutions in the healthcare sector.

  • TechCrunch Disrupt 2026 Tickets Now on Sale!

    TechCrunch Disrupt 2026 Tickets Now on Sale!

    The hum of servers, a constant thrum in the background, almost drowns out the chatter. It’s early January 2026, and the engineering team at a San Francisco-based AI startup is huddled around a monitor, running thermal tests on the latest GPU prototypes. Their focus is intense, the air thick with the smell of coffee and the quiet urgency of a looming deadline. They know the stakes: the next generation of AI models hinges on the performance of this hardware, and the pressure is on.

    Meanwhile, across town, the announcement everyone’s been waiting for dropped: TechCrunch Disrupt 2026 tickets are officially on sale. The event, scheduled for October 13-15 in San Francisco, promises to be a pivotal gathering. Over 10,000 tech leaders, founders, and venture capitalists are expected to attend, making it a prime opportunity to network and get a glimpse of the technologies set to shape the coming years.

    As per reports, early registrants can save up to $680 on their tickets. Plus, the first 500 people to register get a +1 pass at half price. It’s a move that underscores the event’s commitment to accessibility and the value it places on fostering connections within the tech community. The deals, as they say, won’t last forever.

    One of the key themes expected to dominate the conference is the evolution of AI hardware. Analysts at JP Morgan predict that the demand for advanced GPUs will surge in 2026, driven by the rapid growth of large language models (LLMs). The firm forecasts a 40% increase in demand for high-end GPUs, a trend that is already putting pressure on manufacturing capacities. The supply chain, still reeling from the effects of the 2024 chip shortages, faces another challenge. It seems like the constraints imposed by export controls and domestic procurement policies are complicating matters further.

    “The industry is at a critical juncture,” said Sarah Chen, a senior analyst at Gartner, during a recent briefing. “The ability to scale AI models depends directly on the availability of cutting-edge hardware. The next few months will be crucial.”

    The race to secure the best hardware is on. Companies are scrambling to get their hands on the latest chips, with the M300 and future iterations set to define the next generation of AI. Of course, the competition is fierce, and the stakes are high, but the potential rewards are even greater. It’s a complex landscape, a blend of technological innovation and geopolitical maneuvering, all playing out in real-time.

    The release of tickets for TechCrunch Disrupt 2026 feels like a tangible marker of this progress. It’s a chance to see what’s next, to hear from the people at the forefront of these advancements. And for those in the industry, it’s a reminder that the future is being built, brick by digital brick, right now.

  • Preply’s Unicorn Status: Ukrainian Resilience in Language Learning

    Preply’s Unicorn Status: Ukrainian Resilience in Language Learning

    Preply’s Unicorn Status: A Testament to Ukrainian Resilience in Language Learning

    In the dynamic world of online education, certain milestones stand out, signaling not just financial success but also the embodiment of resilience and innovation. Preply, the language learning marketplace, has reached such a milestone, achieving unicorn status with a valuation of $1.2 billion. This achievement, underscored by a recent $150 million funding round, marks a significant chapter in the company’s 14-year journey. The story of Preply is not just one of business growth; it’s a narrative of adapting and thriving in the face of adversity, particularly emphasizing the resilience of its Ukrainian roots.

    A New Chapter for Preply

    Preply, a language learning marketplace, has transformed the way people learn new languages. The platform connects students with tutors for personalized online lessons. The recent investment of $150 million validates Preply’s business model and its potential for further expansion. This funding will likely fuel further product development, market expansion, and the enhancement of its platform. This new valuation is a testament to the hard work and dedication of the Preply team, and it positions the company for continued growth and impact in the language learning sector.

    The Intersection of Business and Resilience

    The story of Preply is interwoven with the broader narrative of Ukraine, where the company originated. The determination to succeed, even amidst challenging circumstances, is a core value, reflecting the spirit of its founders and employees. This resilience has been a key factor in Preply’s ability to navigate various challenges and emerge stronger. The company’s success story is a powerful reminder of how innovation and perseverance can flourish, even when faced with significant obstacles.

    The valuation of Preply at $1.2 billion highlights the increasing demand for accessible and effective language learning solutions. With a globalized world, the need for effective communication is greater than ever before. Preply’s platform provides an important service, connecting learners with tutors from around the world to facilitate language acquisition. The company’s growth reflects a broader trend towards online education and the increasing value placed on language skills in a globalized world.

    Looking Ahead

    Preply’s journey is a powerful example of how businesses can thrive and adapt. With its recent funding and unicorn status, the company is poised to continue its growth trajectory, further solidifying its position in the language learning market. The success of Preply is a source of pride, particularly for its Ukrainian roots. The company’s story serves as an inspiration, demonstrating the power of resilience, innovation, and the pursuit of excellence.

    In conclusion, Preply’s achievement is more than just a financial milestone. It’s a symbol of hope, resilience, and the power of innovation in the face of adversity. As Preply embarks on this new chapter, the world will be watching, eager to see how it continues to shape the future of language learning.